Macrophage infiltration detected at MR imaging in rat kidney allografts: Early marker of chronic rejection?

Radiology

Volumn 240, Issue 3, 2006, Pages 717-724

  Beckmann, Nicolau ^a   Cannet, Catherine ^a   Zurbruegg, Stefan ^a   Haberthür, Reto ^a   Li, Jianping ^a   Pally, Charles ^a   Bruns, Christian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BANFF SCORE; BLOOD CHEMISTRY; CELL INFILTRATION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE CLASSIFICATION; DISEASE MARKER; DOSE RESPONSE; EARLY DIAGNOSIS; HISTOLOGY; IMAGING SYSTEM; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT STRAIN; SCORING SYSTEM; STATISTICAL ANALYSIS; URINALYSIS;

ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; TIME FACTORS;

EID: 33747606751     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2403050873     Document Type: Article

References (37)

1. Djamali A, Premasathian N, Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol 2003;23:306-316.
2. Flechner SM. Minimizing calcineurin inhibitor drugs in renal transplantation. Transplant Proc 2003;35(suppl 3):118S-121S.
3. Loucaidou M, McLean AG, Cairns TD, et al. Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. Transplantation 2003;76:1120-1123.
4. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-2333.
5. Schuurman HJ, Weckbecker G, Bruns C, Beckmann N, Rudin M, Cook NS. Preclinical models of chronic rejection: promises and pitfalls. Transplant Proc 1997;29:2624-2625.
6. Smit-van Oosten A, Navis G, Stegeman CA, et al. Chronic blockade of angiotensin 11 action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation. J Pathol 2001;194: 122-129.
7. Knoll T, Oltersdorf J, Gottmann U, et al. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection. Transpl Int 2003;16:425-429.
8. Schindler R, Tullius SG, Tanriver Y, et al. Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy. Kidney Int 2003;63: 2302-2308.
9. Beckmann N, Hof RP, Rudiri M. The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed 2000;13:329-348.
10. Beckmann N, Joergensen J. Bruttel K, Rudin M, Schuurman HJ. Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat. Transpl Int 1996;9: 175-183.
11. Cook NS, Zerwes HG, Rudin M, Beckmann N, Schuurman HJ. Chronic graft loss: dealing with the vascular alterations in solid organ transplantation. Transplant Proc 1998; 30:2413-2418.
12. Gaschen L, Schuurman HJ, Bruttel K, Tanner M, Beckmann N. MRI and ultrasonographic detection of morphologic and hemodynamic changes in chronic renal allograft rejection in the rat. J Magn Reson Imaging 2001;13:232-241.
13. Yang D, Ye Q, Williams M, et al. USPIO-enhanced dynamic MRI: evaluation of normal and transplanted rat kidneys. Magn Reson Med 2001;46:1152-1163.
14. Beckmann N, Cannet C. Fringeli-Tanner M, et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 2003;49:459-467.
15. Zhang Y, Dodd SJ, Hendrich KS, Williams M, Ho C. Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int 2000;58:1300-1310.
16. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493.
17. Frahm J, Haase A, Matthaei D. Rapid NMR imaging of dynamic processes using the FLASH technique. Magn Reson Med 1986;3: 321-327.
18. Jung CW. Surface properties of snperparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:675-691.
19. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422.
20. Monaco AP, Burke JF Jr, Ferguson RM, et al. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 rouudtable discussion. Am J Kidney Dis 1999;33:150-160.
21. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723.
22. Mahabir RN, Guttmann RD, Lindquist RR. Renal transplantation in the inbred rat. X. A model of "weak histoincompatibility" by major locus matching. Transplantation 1969;8: 369-378.
23. Diamond JR, Tilney NL, Frye J, et al. Progressive albuminuria end glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992;54:710-716.
24. Olsen S, Spencer E, Cockfield S, Marcussen N, Solez K. Endocapillary glomerulitis in the renal allograft. Transplantation 1995;59: 1421-1425.
25. Azuma H, Heemann U, Tullius SG, Tilney NL. Host leukocytes and their products in chronic kidney allograft rejection in rats. Transpl Int. 1994;7(suppl 1):S325-S327.
26. Croker BP, Clapp WL, Abu Shamat AR, Kone BC, Peterson JC. Macrophages and chronic renal allograft nephropathy. Kidney Int Suppl 1996;57:S42-S49.
27. Azuma H, Takahara S, Matsumoto K, et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001;12:1280-1292.
28. Herrevo-Fresneda I, Torras J, Cruzado JM, et al. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol 2003;162:127-137.
29. Ziai F, Nagano H, Kusaka M, et al. Renal allograft protection with losartan in Fisher→Lewis rats: hemodynamics, macrophages, and cytokines. Kidney Int 2000;57: 2618-2625.
30. Harnar P, Szabo A, Muller V. Heemann U. Involvement of interlenkin-2 and growth factors in chronic kidney allograft rejection in rats. Transplant Proc 2001;33:2160-2162.
31. Yang J, Reutzel-Selke A, Steier C, et al. Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-gamma accelerates chronic graft injury in a rat renal allograft model. J Am Soc Nephrol 2003;14:214-225.
32. Grau V, Birgit Herbst B, Steiniger B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res 1998;291:117-126.
33. Le Meur Y, Jose MD, Mu W, Atkins RC, Chadhan SJ. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002;73:1318-1324.
34. Jose MD, Le Meur Y, Atkins RC, Chadban SJ. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 2003;3:294-300.
35. Schuurman HJ, Beckmann N, Briner U, et al. Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995. Transplant Proc 1996;28:3272-3275.
36. Weckbecker G, Pally C, Raulf F, et al. The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc 1997;29:2599-2600.
37. Beckmann N, Mueggler T, Allegrini PR, Laurent D, Rudin M, From anatomy to the target: contributions of magnetic resonance imaging to pre-clinical pharmaceutical research. Anat. Rec 2001;265:85-100.